2018
DOI: 10.1016/j.addbeh.2018.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Remote biochemical verification of tobacco use: Reducing costs and improving methodological rigor with mailed oral cotinine swabs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 11 publications
0
5
0
Order By: Relevance
“…24 The iScreen OFD test produces qualitative binary results within 10 minutes, with reliable detection at cotinine A c c e p t e d M a n u s c r i p t 12 levels of 30 ng/mL, including through remote verification. 25 Participants were provided with written and pictorial instructions for conducting the OFD swab and were instructed to send a photograph of the test result window as an email attachment to the study email account. A blinded outcome assessor evaluated the photograph to determine smoking status.…”
Section: Methodsmentioning
confidence: 99%
“…24 The iScreen OFD test produces qualitative binary results within 10 minutes, with reliable detection at cotinine A c c e p t e d M a n u s c r i p t 12 levels of 30 ng/mL, including through remote verification. 25 Participants were provided with written and pictorial instructions for conducting the OFD swab and were instructed to send a photograph of the test result window as an email attachment to the study email account. A blinded outcome assessor evaluated the photograph to determine smoking status.…”
Section: Methodsmentioning
confidence: 99%
“…Moore et al found that the final results of the swab did not change as a result of the time from collection to mailing, and thus this was a reliable method for quantifying tobacco usage in patients. 22 Future studies should also examine whether a telehealth visit with a provider, combined with the cotinine swabs, can cause behavior change in individuals attempting to reduce their tobacco intake.…”
Section: Pvd Monitoringmentioning
confidence: 99%
“…Each assessment consisted of questionnaires and biochemical verification of participants' smoking status via breath and saliva specimens submitted remotely using a smartphone. Breath specimens were submitted using the handheld, smartphone-compatible iCO™ Smokerlyzer® (coVita, Inc.) CO monitor (Wong et al, 2019), and saliva cotinine levels were measured using the Alere iScreen® OFD Test (New Line Medical) (Moore et al, 2018). With the exception of sociodemographic characteristics that were assessed at intake only, the questionnaires completed at each assessment were largely identical, and queried participants about various secondary outcomes (e.g., nicotine dependence, smoking behavior, depression levels) that will be examined in our ongoing, fully randomized trial examining the current intervention (ClinicalTrials.gov Identifier: NCT03922360).…”
Section: Assessmentsmentioning
confidence: 99%